Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity

Cardiovascular Toxicology

Volumn 2, Issue 1, 2002, Pages 41-51

  Burke, Briant E ^a,b   Mushlin, Phillip S ^c   Cusack, Barry J ^a,b,d   Olson, Stephan J ^b   Gambliel, Herve A ^a,b   Olson, Richard D ^a,b,d  

^a Boise VA Medical Center   (United States)

^b MSTI/MSMRI Research Institute   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anthracycline cardiotoxicity; Cardiomyocyte; Neonatal; Ryanodine receptor; Sarcoplasmic reticulum

Indexed keywords

ANTHRACYCLINE; CAFFEINE; DAUNORUBICIN; DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC; PHOSPHODIESTERASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEART ATRIUM; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; ISOLATED HEART; MALE; MUSCLE FORCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SARCOPLASMIC RETICULUM; AGING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART DISEASE; HEART MUSCLE; MUSCLE RELAXATION; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALIA; ORYCTOLAGUS CUNICULUS; VERTEBRATA;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIBIOTICS, ANTINEOPLASTIC; CAFFEINE; DAUNORUBICIN; DOXORUBICIN; FEMALE; HEART ATRIA; HEART DISEASES; MALE; MUSCLE RELAXATION; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; RABBITS; SARCOPLASMIC RETICULUM;

EID: 0036048965     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:1:41     Document Type: Article

References (40)

1. Young, R.C., Ozols, R.F., and Myers, C.E. (1981). The anthracycline antineoplastic drugs. N. Engl. J. Med. 305:139-153.
2. Cortes, E.P., Lutman, G., Wanka, J., Wang, J.J., Pickren, J., Wallace, J., et al. (1975). Adriamycin: (NSC-123127) cardiotoxicity; a clinico-pathologic correlation. Cancer Chemother. Rep. 6:215-255.
3. Alexander, J., Dainiak, N., Berge, H.J., et al. (1979). Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiography. N. Engl. J. Med. 300:278-283.
4. Lipshultz, S.E., Colan, S.D., Gelber, R.D., Perez-Atayde, A.R., Sallan, S.E., and Sanders, S.P. (1991). Late effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 324:808-815.
5. Grenier, M.A. and Lipshultz, S.E. (1998). Epidemiology of anthracycline cardiotoxicity in children and adults. Semin. Oncol. 25(4 Suppl. 10):72-85.
6. Maylie, J.G. (1982). Excitation-contraction coupling in neonatal and adult myocardium of cat. Am. J Physiol. 242(Heart Circ. Physiol. 11):H834-H843.
7. Nakanishi, T. and Jarmakani, J.M. (1984). Developmental changes in myocardial mechanical function and subcellular organelles. Am. J. Physiol. 246(Heart Circ. Physiol. 15):H651-H625.
8. Fabiato, A. and Fabiato, F. (1978). Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and newborn rat ventricles. Ann. NY Acad. Sci. 307:491-521.
9. Wibo, M., Bravo, G., and Godfraind, T. (1990). Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropyridine and ryanodine receptors. Circ. Res. 68:662-673.
10. Harrer, J.M., Haghighi, K., Kim, H.W., Ferguson, D.G., and Kranias, E.G. (1997). Coordinate regulation of SR Ca-ATPase and phospholamban expression in developing muring heart. Am. J. Physiol. 272(Heart Circ. Physiol. 41):H57-H66.
11. Fill, M. and Coronado, R. (1988). Ryanodine receptor channel of sarcoplasmic reticulum. Trends Neurol. Sci. 11:453-457.
12. Page, E., Earley, J., and Power, B. (1974). Normal growth of ultrastructures in rat left ventricular myocardial cells. Circ. Res. 35(Suppl. 11):II-12-II-16.
13. Hirakow, R., Gotoh, T., and Watanabe, T. (1980). Quantitative studies on the ultrastructural differentiation and growth of mammalian cardiac muscle cells: I. The atria and ventricles of the rat. Acta. Anat. (Basel) 108:144-152.
14. Horenstein, M.S., Vander-Heide, R.S., and L'Ecuyer, T.J. (2000). Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol. Genet. Metab. 71:436-444.
15. Solem, L.E., Heller, L.J., and Wallace, K.B. (1996). Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by. J. Mol. Cell. Cardiol. 28:1023-1032.
16. Boucek, R.J. Jr., Olson, R.D., Brenner, D.E., Ogunbunmi, E.M., Inui, M., and Fleischer, S. (1987). The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps: a correlative study of cardiac muscle with isolated membrane fractions. J. Biol. Chem. 262:15,851-15,856.
17. Hagane, K., Akera, T., and Berlin, J.R. (1988). Doxorubicin: mechanism of cardiodepressant actions in guinea pigs. J. Pharmacol. Exp. Ther. 246:655-661.
18. Boucek, R.J. Jr., Buck, S.H., Scott, F., Oquist, N.L., Fleischer, S., and Olson, R.D. (1993). Anthracycline-induced tension in permeabilized cardiac fibers: evidence for the activation of the calcium release channel of sarcoplasmic reticulum. J. Mol. Cell Cardiol. 25:249-259.
19. Burke, B.E., Gambliel, H., Olson, R.D., Bauaer, F.K., and Cusack, B.J. (2000). Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat. Br. J. Pharmacol. 131:1-4.
20. Olson, R.D., Li, X., Palade, P., et al. (2000). Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol. Toxicol. Appl. Pharmacol. 169:168-176.
21. Arai, M., Tomaru, K., Takizawa, T., et al. (1998). Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J. Mol. Cell Cardiol. 30:243-254.
22. Olson, R.D., Mushlin, P.S., Brenner, D.E., et al. (1988). Doxorubicin cardiotoxicity may be due to its metabolite, doxorubicinol. Proc. Natl. Acad. Sci. USA 85:3585-3589.
23. Pessah, I.N., Durie, E.L., Schiecit, M.J., and Zimany, I. (1990). Anthraquinone-sensitized Ca release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol. Pharmacol. 37:503-514.
24. Iarussi, D., Auricchia, U., Agretto, A., et al. (1994). Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol. Aspects Med. 15(Suppl.):207-212.
25. Kurabayashi, M., Jeyaseelan, R., and Kedes, L. (1993). Antineoplastic agent doxorubicin inhibits myogenic differentiation of C2 myoblasts. J. Biol. Chem. 268:5524-5529.
26. Bers, D.M. (1985). Ca influx and sarcoplasmic reticulum Ca release in cardiac muscle activation during postrest recovery. Am. J. Physiol. 248:H366-H381.
27. Bouchard, R.A. and Bose, D. (1989). Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am. J. Physiol. 257:H2036-H2047.
28. Kim, D.H., Landry, A.B. III, Lee, Y.S., and Katz, A.M. (1989). Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J. Mol. Cell Cardiol. 21:433-436.
29. DuBell, W.H. and Houser, S.R. (1990). Rest decay of calcium transients and contractility in feline ventricular myocytes. Am. J. Physiol. 259:H395-H402.
30. Gombosova, I., Boknik, P., Kirchhefer, U., et al. (1998). Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases. Am. J. Physiol. 274(Heart Circ. Physiol. 43):H2123-H2132.
31. Arai, M., Otsu, K., MacLennan, D.H., and Periasamy, M. (1992). Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development. Am. J. Physiol. 262(Cell Physiol. 31):C614-C620.
32. Klitzner, T.S. and Freidman, W.F. (1989). A diminished role for the sarcoplasmic reticulum in newborn myocardial contraction: effects of ryanodine. Pediatr. Res. 26:98-101.
33. Bouchard, R.A. and Bose, D. (1989). Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am. J. Physiol. 257:H2036-H2047.
34. Sutko, J.L., Bers, D.M., and Reeves, J.P. (1986). Postrest inotropy in rabbit ventricle: Na-Ca exchange determines sarcoplasmic reticulum Ca content. Am. J. Physiol. 250:H654-H661.
35. Frank, K. and Kranias, E.G. (2000). Phospholamban and cardiac contractility: Review. Ann. Med. 32:572-578.
36. Yard, N. and Ball, H.A. (1993). Effects of cyclopiazonic acid, an inhibitor of SR Ca ATPase, on the force-frequency relation of guinea-pig atria. Br. J. Pharmacol. 110(Suppl.):53P.
37. DuBell, W.H. and Houser, S.R. (1990). Rest decay of calcium transients and contractility in feline ventricular myocytes. Am. J. Physiol. 259:H395-H402.
38. Langer, G.A. (1992). Calcium and the heart: exchange at the tissue, cell and organelle levels. FASEB J. 6:893-902.
39. Cusack, B.J., Young, S.P., and Olson, R.D. (1995). Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues of the rat. Cancer Chemother. Pharmacol. 35:213-218.
40. Stewart, D.J., Grewaal, D., Green, R.M., et al. (1993). Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer Res. 13:1945-1952.